temafloxacin has been researched along with lomefloxacin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 15 (71.43) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
| Erwin, ME; Jones, RN | 1 |
| Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
| Garcia, I; Pascual, A; Perea, EJ | 1 |
| Nix, DE; Symonds, WT | 1 |
| Gelber, RH; Iranmanesh, A; Murray, L; Siu, P; Tsang, M | 1 |
| Andrews, JM; Baldwin, DR; Honeybourne, D; Wise, R | 1 |
| Conejo, MC; García, I; Pascual, A; Perea, EJ | 1 |
| Barry, AL; Fuchs, PC | 2 |
| Pattyn, SR | 1 |
| Goodman, LJ; Kaplan, RL; Nelson, JA; Segreti, J; Trenholme, GM | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Gage, TW | 1 |
| Iakovlev, SV; Iakovlev, VP; Izotova, GN | 1 |
| Baumann-Wilschke, I; Förster, C; Rücker, M; Shakibaei, M; Stahlmann, R; Vormann, J | 1 |
| Baumann-Wilschke, I; Rücker, M; Shakibaei, M; Stahlmann, R | 1 |
| Fukuda, H; Kawamura, Y | 1 |
3 review(s) available for temafloxacin and lomefloxacin
| Article | Year |
|---|---|
Quinolone antibiotics.
Topics: | 2019 |
Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Humans; Quinolones | 1992 |
[Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Pefloxacin; Quinolones; Renal Insufficiency | 1995 |
18 other study(ies) available for temafloxacin and lomefloxacin
| Article | Year |
|---|---|
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1991 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
Topics: Agar; Anti-Infective Agents; Drug Stability; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quinolones | 1992 |
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
Topics: Anti-Infective Agents; Cefdinir; Ceftizoxime; Cephalosporins; Diffusion; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Quinolones | 1992 |
Two new fluoroquinolones.
Topics: Anti-Infective Agents; Clinical Trials as Topic; Drug Interactions; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Urinary Tract Infections | 1992 |
Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells.
Topics: Animals; Anti-Infective Agents; Cell Line; Cell Survival; Cells, Cultured; Fibroblasts; Fluoroquinolones; Humans; Macrophages; Neutrophils; Opsonin Proteins; Peritoneal Dialysis, Continuous Ambulatory; Quinolones; Temperature; Vero Cells | 1992 |
Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
Topics: Animals; Anti-Infective Agents; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Pefloxacin; Quinolones | 1992 |
Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Injections, Intravenous; Lung; Quinolones | 1991 |
Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluorescence; Fluoroquinolones; Humans; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1991 |
Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests; Quinolones | 1991 |
Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Leprosy; Mice; Mycobacterium leprae; Quinolones | 1991 |
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Diarrhea; Fluoroquinolones; Humans; Quinolones | 1989 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
New drugs from 1991-1992.
Topics: 1-Naphthylamine; Anti-Bacterial Agents; Anti-Infective Agents; Anticholesteremic Agents; Antineoplastic Agents; Antiviral Agents; Azithromycin; Butanones; Cardiovascular Agents; Clarithromycin; Drug Approval; Drug Combinations; Drug Interactions; Enoxacin; Finasteride; Flumazenil; Fluoroquinolones; Humans; Ketorolac Tromethamine; Lactams; Nabumetone; Pyridines; Quinolones; Sertraline; Tolmetin; Tromethamine; United States; United States Food and Drug Administration; Zolpidem | 1993 |
Selection of a fluoroquinolone-class disk for susceptibility tests.
Topics: Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1993 |
Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; Extremities; Fleroxacin; Fluoroquinolones; Magnesium Deficiency; Mice; Microscopy, Electron; Ofloxacin; Pefloxacin; Quinolones | 1998 |
Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Infective Agents; Calcium; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Fluoroquinolones; In Vitro Techniques; Levofloxacin; Limb Buds; Magnesium; Male; Mice; Mice, Inbred Strains; Ofloxacin; Piperazines; Pregnancy; Quinolones | 2002 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |